Follow up of atypical squamous cell pap smears in iraqi women

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 7, 2012, Pages 3455-3460

  Pity, Intisar S ^a   Shamdeen, Maida Y ^a   Wais, Shawnim A ^a  

^a UNIVERSITY OF DUHOK   (Iraq)

Author keywords

ASC H; ASCUS; High risk HPV DNA; Pap smear

Indexed keywords

EID: 84873596470     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.7.3455     Document Type: Article

References (32)

1. Alli PM, Ali SZ (2003). Atypical squamous cells of undetermined significance-rule out high grade squamous intraepithelial lesion: cytopathologic characteristics and clinical correlates. Diagn Cytopathol, 28, 308-12.
2. ASCUS-LSIL Traige Study (ALTS) Group (2003). Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol, 188, 1381-2.
3. Bandyopadhyay S, Austin M, Dabbs D, Zhao C (2008). Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results. Arch Pathol Lab Med, 132, 1874-81.
4. Bansal M, Li Z, Zhao C (2012). Correlation of histopathologic/ cytologic follow-up findings with vaginal ASC-US and ASC-H Papanicolaou test and HPV test results. American Journal of Clinical Pathology, 137, 437-43.
5. Barcelos ACM, Michelin MA, Adad SJ, Murta EFC (2011). Atypical squamous cells of undetermined significance: Bethesda classification and association with human papillomavirus. Infectious Diseases in Obstetrics and Gynecology, 2011. doi:10.1155/2011/904674.
6. Barreth D, Schepansky A, Capstick V, et al (2006). Atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H): a result not to be ignored. J Obstet Gynaecol Can, 28, 1095-8.
7. Chivukula M, Shidham VB (2006). ASC-H in Pap test-definitive categorization of cytomorphological spectrum. CytoJournal, 3, 14.
8. CytrynI A, Russomano FB, de Camargo MJ, et al (2009). Prevalence of cervical intraepithelial neoplasia grades II/ III and cervical cancer in patients with cytological diagnosis of atypical squamous cells when high-grade intraepithelial lesions (ASC-H) cannot be ruled out. Sao Paulo Med J, 127, 283-7.
9. De Roda Husman A, Walboomers JMM, Van Den Brule AJC, et al (1995). The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. Journal of General Virology, 76, 1057-62.
10. Duncan LD, Jacob SV (2005). Atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion: The practice experience of a hospital-based reference laboratory with this new Bethesda system diagnostic category. Diagnostic Cytopathol, 32, 243-6.
11. Gerber S, De Grandi P, Petignat P, Mihaescu A (2001). Colposcopic evaluation after a repeat atypical squamous cells of undetermined significance (ASCUS) smear. Int J Gynaecol Obstet, 75, 251-5.
12. Ghaemmaghami F, Ensani F, Behtash N, Hosseini-Nejad E (2005). Pap smear with atypical squamous cells of undetermined significance. Arch Iranian Med, 8, 192-6.
13. Jacobs MV, Snijders PJ, van den Brule AJ, et al (1997). A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J ClinMicrobiol, 35, 791-5.
14. Kaygusuz EI, Çetİner H, Şahİn D (2011). LSIL/ASC-H (LSIL-H) in cervicovaginal smear: Histopathological outcomes and clinical significance. TJPath, 27, 45-50.
15. Lee SJ, Song SY, Kim BG, Lee Park JH, Bae CSDS (2006). Analyses of atypical squamous cells refined by the 2001 Bethesda System: the distribution and clinical significance of follow-up management. Int J Gynecol Can, 16, 664-9.
16. Louro AP, Roberson J, Eltoum I, Chhieng DC (2003). Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion. A Follow-up study of conventional and liquid-based preparations in a high-risk population. Am J Clin Pathol, 120, 392-7.
17. Manos MM, Kinney WK, Hurley LB, et al (1999). Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA, 281, 1605-10.
18. Michelow P, Hartman I, Schulze D, et al (2010). Atypical squamous cells, cannot exclude high grade squamous intraepithelial (ASC-H) in HIV-positive women. Cytojournal, 7, 8.
19. Mood NI, Haratian A (2004). Atypical squamous cells of undetermined significance: A cytohistologic study. Acta Medica Iranica, 42, 295-9.
20. Murta EFC, Silva CS, Vieira JB, Khabbaz KM, Adad SJ (2007). Cervical neoplasia after diagnosis and follow-up of women with atypical squamous cells of undetermined significance. Clin Exp Obstet Gynecol, 34, 219-22.
21. NCI Bethesda System 2001 (2001). Bethesda system for reporting results of cervicovaginal cytologic disease. Available at: http://www.Bethesda2001.cancer.gov.
22. Roche D, Spicer N (2001). The clinical significance of atypical squamous cells of undetermined significance: a laboratory audit of cervical reporting. N Z Med J, 114, 64-6.
23. Saad RS, Dabbs DJ, Kordunsky L, et al (2006). Clinical significance of cytologic diagnosis of atypical squamous cells, cannot exclude high grade, in perimenopausal and postmenopausal women. Am J Clin Pathol, 126, 381-8.
24. Selvaggi SM (2003). Reporting of atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion (ASC-H) on cervical samples: is it significant? Diagn Cytopathol, 29, 38-41.
25. Sherman ME, Solomon D, Schiffman M (2001). Qualification of ASCUS a comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study. Am J Clin Pathol, 116, 386-94.
26. Sherman ME, Castle PE, Solomon D (2006). Cervical cytology of atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H). Cancer, 108, 298-305.
27. Solomon D, Schiffman M, Tarone (2001). Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. JNCI, 93, 293-9.
28. Srodon M, Parry DH, Ronnett BM (2005). Atypical squamous cells, cannot exclude high grade squamous intraepithelial lesion: diagnostic performance, human papillomavirus testing and follow up results. Cancer, 108, 32-8.
29. Tewari LCR, Chaudhary CA (2010). Atypical Squamous Cells of Undetermined Significance: A Follow up Study. MJAFI, 66, 225-7.
30. Van den Brule AJ, Pol R, Fransen-Daalmeijer N, et al (2002). GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J ClinMicrobiol, 40, 779-87.
31. Youens KE, Hosler GA, Washington PJ, Jenevein EP, Murphy KM (2011). Clinical Experience with the Cervista HPV HR Assay. J Mol Diagn, 13, 160-6.
32. Zhao C, Zhao S, Heider A, Austin RM (2010). Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell Papanicolaou test abnormalities. Archives of Pathology & Laboratory Medicine, 134, 1130-5.